New drug’s potentially fatal side effects obscured by ‘soothing acronym,’ doctors say

Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave her headaches so severe they sent her to bed. A week after the third dose, she was at a restaurant with her …

This post was originally published on this site

Marketing block

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign Up for Updates

Get the latest stock market news from Phil by signing up for our newsletter!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

New drug’s potentially fatal side effects obscured by ‘soothing acronym,’ doctors say

Marketing block

Recent Posts

Media Consolidation

What does 2025 hold for interest rates, inflation and the American consumer?

The Future of Syria and Turkey’s Role

Killing the budget bill let China off the hook (shared)

Ranked: The World’s 10 Largest Companies by Revenue

Microsoft Bundling Practices Focus of Federal Antitrust Probe

Sign Up for Updates